Cargando…
Neural effects of gut‐ and brain‐derived glucagon‐like peptide‐1 and its receptor agonist
Glucagon‐like peptide‐1 (GLP‐1) is derived from both the enteroendocrine L cells and preproglucagon‐expressing neurons in the nucleus tractus solitarius (NTS) of the brain stem. As GLP‐1 is cleaved by dipeptidyl peptidase‐4 yielding a half‐life of less than 2 min, it is plausible that the gut‐derive...
Autores principales: | Katsurada, Kenichi, Yada, Toshihiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854507/ https://www.ncbi.nlm.nih.gov/pubmed/27186358 http://dx.doi.org/10.1111/jdi.12464 |
Ejemplares similares
-
Glucagon‐like peptide‐1: The missing link in the metabolic clock?
por: Brubaker, Patricia L, et al.
Publicado: (2016) -
Mechanisms underlying glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 secretion
por: Reimann, Frank, et al.
Publicado: (2016) -
Carbohydrate‐induced secretion of glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1
por: Seino, Yusuke, et al.
Publicado: (2016) -
Glucagon‐like peptide‐1 and cholecystokinin production and signaling in the pancreatic islet as an adaptive response to obesity
por: Linnemann, Amelia K, et al.
Publicado: (2016) -
Anti‐atherogenic and anti‐inflammatory properties of glucagon‐like peptide‐1, glucose‐dependent insulinotropic polypepide, and dipeptidyl peptidase‐4 inhibitors in experimental animals
por: Hirano, Tsutomu, et al.
Publicado: (2016)